<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;ff=20250324181112
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;ff=20250324181112" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Mon, 24 Mar 2025 22:11:15 +0000</lastbuilddate>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Successful percutaneous retrieval of a detached MitraClip® in the left atrium via maintained gripper line: a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124626/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: Mitral valve transcatheter edge-to-edge repair (M-TEER) with MitraClip® has become an established treatment for high-risk patients with mitral regurgitation (MR). While device-related complications are known, they typically occur during leaflet grasping or after deployment, with most issues arising from device-tissue interaction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 8;9(3):ytaf124. doi: 10.1093/ehjcr/ytaf124. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Mitral valve transcatheter edge-to-edge repair (M-TEER) with MitraClip® has become an established treatment for high-risk patients with mitral regurgitation (MR). While device-related complications are known, they typically occur during leaflet grasping or after deployment, with most issues arising from device-tissue interaction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: A 67-year-old woman with dilated cardiomyopathy underwent M-TEER for severe functional MR. Although resistance was noted during initial device preparation and loading, limited functional testing appeared normal and the procedure was continued. During clip manipulation in the left atrium, mechanical resistance in the arm positioner led to unexpected detachment of the MitraClip, connected only by the gripper line. Through careful traction under echocardiographic and fluoroscopic guidance, we successfully retrieved the clip percutaneously. The procedure was completed with new MitraClip systems, achieving mild residual MR. The patient's symptoms improved from New York Heart Association Classes II and III to I, with sustained improvement during 4.5 years of follow-up.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: This case reveals a novel mechanism of MitraClip detachment through mechanical failure during preparation, where introducer damage led to harness deformation and subsequent clip detachment. Among available retrieval options, we demonstrated the feasibility of direct traction retrieval under specific conditions, offering a less invasive solution when gripper line connection is maintained. This case emphasizes the importance of meticulous device inspection and preparation, while providing insights into both failure mechanisms and retrieval strategies in M-TEER complications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124626/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40124626</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11926327/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">PMC11926327</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf124>10.1093/ehjcr/ytaf124</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124626</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Hiroto Yagasaki</dc:creator>
<dc:creator>Takeki Suzuki</dc:creator>
<dc:creator>Ryota Watanabe</dc:creator>
<dc:creator>Keitaro Watanabe</dc:creator>
<dc:creator>Toshiyuki Noda</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Successful percutaneous retrieval of a detached MitraClip® in the left atrium via maintained gripper line: a case report</dc:title>
<dc:identifier>pmid:40124626</dc:identifier>
<dc:identifier>pmc:PMC11926327</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf124</dc:identifier>
</item>
<item>
<title>Percutaneous coronary intervention in anomalous aortic origin of a coronary artery: a rare case report of a dual-left anterior descending artery with a pre-pulmonary course</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124625/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: This case underscores the importance of CT scan in delineating the anatomical characteristics of AAOCA, and the feasibility and efficacy of PCI in symptomatic, non-high-risk AAOCA, emphasizing its role as a minimally invasive alternative within a multidisciplinary approach.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 3;9(3):ytaf112. doi: 10.1093/ehjcr/ytaf112. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Anomalous aortic origin of a coronary artery (AAOCA) of the left anterior descending artery (LAD) is a rare congenital anomaly. Their percutaneous coronary intervention (PCI) when an ischaemia is documented remains challenging.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE PRESENTATION: We report the case of a 52-year-old patient from Bangladesh with dual-origin LAD arising from both left and right sinus with a pre-pulmonary course, presenting with exertional angina and documented myocardial ischaemia. Computed tomography (CT) scan confirmed the anatomical course of the AAOCA. Percutaneous coronary intervention was successfully performed using tailored techniques to treat significant atherosclerotic lesions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This case underscores the importance of CT scan in delineating the anatomical characteristics of AAOCA, and the feasibility and efficacy of PCI in symptomatic, non-high-risk AAOCA, emphasizing its role as a minimally invasive alternative within a multidisciplinary approach.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124625/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40124625</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925849/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">PMC11925849</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf112>10.1093/ehjcr/ytaf112</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124625</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Sara Jourani</dc:creator>
<dc:creator>Zakaria Laraichi</dc:creator>
<dc:creator>Mehdi Saighi Bouaouina</dc:creator>
<dc:creator>Cedric Gaultier</dc:creator>
<dc:creator>Hakim Benamer</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Percutaneous coronary intervention in anomalous aortic origin of a coronary artery: a rare case report of a dual-left anterior descending artery with a pre-pulmonary course</dc:title>
<dc:identifier>pmid:40124625</dc:identifier>
<dc:identifier>pmc:PMC11925849</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf112</dc:identifier>
</item>
<item>
<title>Bachmann's bundle and upper septal inter-atrial connections as key paths for a biatrial macro re-entrant circle: a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124624/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: The Bachmann's bundle has been described as a key route for re-entrant circuits in biatrial tachycardias. Septal inter-atrial muscular connections were discovered a while ago, but evidence on their potential role in re-entrant tachycardias is lacking.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 7;9(3):ytaf119. doi: 10.1093/ehjcr/ytaf119. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The Bachmann's bundle has been described as a key route for re-entrant circuits in biatrial tachycardias. Septal inter-atrial muscular connections were discovered a while ago, but evidence on their potential role in re-entrant tachycardias is lacking.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: We describe an atrial macro re-entrant circuit presented as a wide complex tachycardia that utilized the Bachmann's bundle, septal inter-atrial connections, and a limited area of the anterior left atrial myocardium in a patient with previous multiple atrial fibrillation ablation procedures. This tachycardia was diagnosed by using a combination of electrophysiological visualization modalities and was terminated by a single radiofrequency application.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: The inter-atrial muscular connections can pose a major contribution to the mechanism of biatrial tachycardias, especially in patients after extensive left atrial ablation. Thorough mapping modalities, including entrainment stimulation, facilitate a correct diagnosis. Understanding inter-atrial connection anatomy is crucial for the detection and successful ablation of such tachycardia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124624/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40124624</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925846/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">PMC11925846</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf119>10.1093/ehjcr/ytaf119</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124624</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Heber Ivan Condori Leandro</dc:creator>
<dc:creator>Dmitry S Lebedev</dc:creator>
<dc:creator>Lubov B Mitrofanova</dc:creator>
<dc:creator>Evgeny N Mikhaylov</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Bachmann's bundle and upper septal inter-atrial connections as key paths for a biatrial macro re-entrant circle: a case report</dc:title>
<dc:identifier>pmid:40124624</dc:identifier>
<dc:identifier>pmc:PMC11925846</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf119</dc:identifier>
</item>
<item>
<title>Shear wave elastography to unmask differences in myocardial stiffness between athletes and sedentary non-athletes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: SW elastography reveals reduced myocardial stiffness in athletes compared to sedentary non-athletes at rest and during exercise, which is not detected by conventional echocardiographic measurements. Exercise-induced changes in SW velocities after AVC may potentially serve as an early marker for detecting diastolic dysfunction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Imaging Methods Pract. 2025 Mar 21;2(4):qyaf023. doi: 10.1093/ehjimp/qyaf023. eCollection 2024 Oct.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Myocardial stiffening naturally occurs with aging and contributes to diastolic dysfunction. Assessing myocardial stiffness non-invasively could improve the sensitivity of diastolic function evaluation in clinical practice. Shear wave (SW) elastography is a non-invasive tool for quantifying myocardial stiffness, where higher SW velocities indicate increased stiffness. We investigated whether SW elastography could detect differences in myocardial stiffness between athletes and sedentary non-athletes and, during exercise, reveal differences in operational stiffness that may indicate diastolic dysfunction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: We enrolled 20 master athletes (median age 60 [IQR 59-66] years) and 17 sedentary non-athletes (median age 58 [IQR 52-71] years). Standard exercise echocardiography revealed no significant differences in diastolic function between the groups. Additionally, ultra-high frame rate imaging was used to measure SW velocities after mitral valve closure (MVC) and aortic valve closure (AVC) at rest and during exercise. At rest, athletes had lower SW velocities after MVC compared to sedentary non-athletes (3.2 ± 0.4 m/s vs. 3.9 ± 0.7 m/s, respectively, <i>P</i> = 0.003). During exercise, SW velocities after AVC significantly increased in sedentary non-athletes but not in athletes (+1.6 ± 1.6 cm/s increase per 1% power output increase vs. 0.0 ± 0.8 cm/s, respectively, <i>P</i> = 0.006). An inverse correlation was found between the increase of SW velocity after AVC during exercise and VO<sub>2</sub>max (<i>r</i> = -0.51, <i>P</i> = 0.003).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: SW elastography reveals reduced myocardial stiffness in athletes compared to sedentary non-athletes at rest and during exercise, which is not detected by conventional echocardiographic measurements. Exercise-induced changes in SW velocities after AVC may potentially serve as an early marker for detecting diastolic dysfunction.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40124097</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925635/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">PMC11925635</a> | DOI:<a href=https://doi.org/10.1093/ehjimp/qyaf023>10.1093/ehjimp/qyaf023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124097</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Karim Taha</dc:creator>
<dc:creator>Youri Bekhuis</dc:creator>
<dc:creator>Ruben de Bosscher</dc:creator>
<dc:creator>Christophe Dausin</dc:creator>
<dc:creator>Marta Orlowska</dc:creator>
<dc:creator>Ahmed S Youssef</dc:creator>
<dc:creator>Stéphanie Bézy</dc:creator>
<dc:creator>Véronique Cornelissen</dc:creator>
<dc:creator>Lieven Herbots</dc:creator>
<dc:creator>Rik Willems</dc:creator>
<dc:creator>Jens-Uwe Voigt</dc:creator>
<dc:creator>Jan D'hooge</dc:creator>
<dc:creator>Guido Claessen</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Imaging methods and practice</dc:source>
<dc:title>Shear wave elastography to unmask differences in myocardial stiffness between athletes and sedentary non-athletes</dc:title>
<dc:identifier>pmid:40124097</dc:identifier>
<dc:identifier>pmc:PMC11925635</dc:identifier>
<dc:identifier>doi:10.1093/ehjimp/qyaf023</dc:identifier>
</item>
<item>
<title>Focus on old and emerging risk factors: familial hypercholesterolaemia, lipoprotein(a), and skeletal muscle adiposity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123524/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 24;46(12):1083-1087. doi: 10.1093/eurheartj/ehaf124.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123524/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123524</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf124>10.1093/eurheartj/ehaf124</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123524</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on old and emerging risk factors: familial hypercholesterolaemia, lipoprotein(a), and skeletal muscle adiposity</dc:title>
<dc:identifier>pmid:40123524</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf124</dc:identifier>
</item>
<item>
<title>Antispasmodic Medications to Optimize Long-Term Radial Artery Graft Patency in CABG</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123510/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 24:e015199. doi: 10.1161/CIRCINTERVENTIONS.125.015199. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123510/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123510</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.125.015199>10.1161/CIRCINTERVENTIONS.125.015199</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123510</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Dominique Vervoort</dc:creator>
<dc:creator>Stephen E Fremes</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>Antispasmodic Medications to Optimize Long-Term Radial Artery Graft Patency in CABG</dc:title>
<dc:identifier>pmid:40123510</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.125.015199</dc:identifier>
</item>
<item>
<title>Utility of 3D Intracardiac Echocardiography in TriClip: A Future Without Transesophageal Echocardiography?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123502/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Imaging. 2025 Mar 24:e017738. doi: 10.1161/CIRCIMAGING.124.017738. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123502/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123502</a> | DOI:<a href=https://doi.org/10.1161/CIRCIMAGING.124.017738>10.1161/CIRCIMAGING.124.017738</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123502</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Fei Yu</dc:creator>
<dc:creator>Scott Dougherty</dc:creator>
<dc:creator>Kent Chak-Yu So</dc:creator>
<dc:creator>Kevin Ka-Ho Kam</dc:creator>
<dc:creator>Chenxu Zhao</dc:creator>
<dc:creator>Xinghua Shan</dc:creator>
<dc:creator>Alex Pui-Wai Lee</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular imaging</dc:source>
<dc:title>Utility of 3D Intracardiac Echocardiography in TriClip: A Future Without Transesophageal Echocardiography?</dc:title>
<dc:identifier>pmid:40123502</dc:identifier>
<dc:identifier>doi:10.1161/CIRCIMAGING.124.017738</dc:identifier>
</item>
<item>
<title>Improving Cardiovascular Health Through the Consideration of Social Factors in Genetics and Genomics Research: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123498/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>Cardiovascular health (CVH) is affected by genetic, social, and genomic factors across the life course, yet little research has focused on the interrelationships among them. An extensive body of work has documented the impact of social determinants of health at both the structural and individual levels on CVH, highlighting pathways in which racism, housing, violence, and neighborhood environments adversely affect CVH and contribute to disparities in cardiovascular disease. Genetic factors have...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Qual Outcomes. 2025 Mar 24:e000138. doi: 10.1161/HCQ.0000000000000138. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular health (CVH) is affected by genetic, social, and genomic factors across the life course, yet little research has focused on the interrelationships among them. An extensive body of work has documented the impact of social determinants of health at both the structural and individual levels on CVH, highlighting pathways in which racism, housing, violence, and neighborhood environments adversely affect CVH and contribute to disparities in cardiovascular disease. Genetic factors have also been identified as contributors to risk for cardiovascular disease. Emerging evidence suggests that social factors can interact with genetic susceptibility to affect disease risk. Increasingly, social factors have been shown to affect epigenetic markers such as DNA methylation, which can regulate gene and protein expression. This is a potential biological mechanism through which exposure to poor social determinants of health becomes physically embodied at the molecular level, potentially contributing to the development of suboptimal CVH and chronic disease, thus reinforcing and propagating health disparities. The objective of this statement is to highlight and summarize key literature that has examined the joint associations between social, genetic, and genomic factors and CVH and cardiovascular disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123498/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123498</a> | DOI:<a href=https://doi.org/10.1161/HCQ.0000000000000138>10.1161/HCQ.0000000000000138</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123498</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Shakira F Suglia</dc:creator>
<dc:creator>Bertha Hidalgo</dc:creator>
<dc:creator>Andrea A Baccarelli</dc:creator>
<dc:creator>Andres Cardenas</dc:creator>
<dc:creator>Scott Damrauer</dc:creator>
<dc:creator>Amber Johnson</dc:creator>
<dc:creator>Kaitlin Key</dc:creator>
<dc:creator>Mingyu Liang</dc:creator>
<dc:creator>Jared W Magnani</dc:creator>
<dc:creator>Brittany Pate</dc:creator>
<dc:creator>Mario Sims</dc:creator>
<dc:creator>Gabriel S Tajeu</dc:creator>
<dc:creator>American Heart Association Social Determinants of Health Committee of the Council on Epidemiology and Prevention and Council on Quality of Care and Outcomes Research; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; Council on Hypertension; Council on Lifestyle and Cardiometabolic Health; and Council on Peripheral Vascular Disease</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular quality and outcomes</dc:source>
<dc:title>Improving Cardiovascular Health Through the Consideration of Social Factors in Genetics and Genomics Research: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:40123498</dc:identifier>
<dc:identifier>doi:10.1161/HCQ.0000000000000138</dc:identifier>
</item>
<item>
<title>Determinants and Prognostic Value of Early Gadolinium Enhancement-Derived Myocardial Salvage Index in STEMI</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123493/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: EGE-derived MSI was associated with prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow and microvascular injuries. It was an independent predictor of major adverse cardiac events. Our results highlight the prognostic potential of EGE imaging in acute myocardial infarction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Imaging. 2025 Mar 24:e017830. doi: 10.1161/CIRCIMAGING.124.017830. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: T2-weighted imaging is commonly used to measure myocardial salvage in reperfused myocardial infarction but is hindered by poor reproducibility and indistinct boundaries. Early gadolinium enhancement (EGE) emerges as an alternative for measuring the area at risk. This study aims to evaluate the determinants of the myocardial salvage index (MSI) derived from EGE and its prognostic implications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We analyzed acute cardiac magnetic resonance scans of 453 reperfused patients with ST-segment-elevation myocardial infarction (mean age, 60±12 years; 389 men) from April 2017 to July 2023 at a single center retrospectively. EGE was collected at 3 minutes after contrast agent injection, where hyperintense areas (signal intensities >; mean+2SD of remote myocardium) were considered as the area at risk, plus the hypointense core within. MSI was calculated as the ratio of salvageable myocardium to the area at risk. Major adverse cardiovascular events included cardiovascular death, hospitalization for heart failure, reinfarction, and unplanned revascularization for the target vessel.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: During a median follow-up of 3.2 years (interquartile range, 1.6-4.7 years), at least one major adverse cardiac event occurred in 91 participants (20.1%). The median MSI was 35.0% (interquartile range, 22.9-59.5%), with smaller MSI observed in patients with larger infarcts (<i>P</i>&lt;0.001). Linear regression identified prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow (β=3.35, <i>P</i>&lt;0.001) and microvascular obstruction (β=-11.92, <i>P</i>&lt;0.001) as independent determinants of MSI. Multivariable Cox regression showed that every 10% increase in MSI was associated with a 32% reduction in major adverse cardiac event risk (hazard ratio, 0.68 [95% CI, 0.53-0.86]; <i>P</i>=0.001). A graded response was observed between MSI and cardiovascular death and reinfarction. MSI greater than the median was associated with nontarget vessel-related reinfarctions but not target vessel-related ones (nontarget, <i>P</i>=0.027; target vessel, <i>P</i>=0.36). Good reproducibility was reported with EGE-measured area at risk (intraobserver, intraclass correlation coefficient [ICC]=0.95; interobserver, ICC=0.89).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: EGE-derived MSI was associated with prepercutaneous coronary intervention Thrombolysis in Myocardial Infarction flow and microvascular injuries. It was an independent predictor of major adverse cardiac events. Our results highlight the prognostic potential of EGE imaging in acute myocardial infarction.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123493/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123493</a> | DOI:<a href=https://doi.org/10.1161/CIRCIMAGING.124.017830>10.1161/CIRCIMAGING.124.017830</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123493</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Jin-Yi Xiang</dc:creator>
<dc:creator>Jin-Yu Zheng</dc:creator>
<dc:creator>Yi-Si Dai</dc:creator>
<dc:creator>Ling-Yi Yu</dc:creator>
<dc:creator>Yu-Fan Qian</dc:creator>
<dc:creator>Wei-Hui Xie</dc:creator>
<dc:creator>Ruo-Yang Shi</dc:creator>
<dc:creator>Bing-Hua Chen</dc:creator>
<dc:creator>Jun Pu</dc:creator>
<dc:creator>Lian-Ming Wu</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular imaging</dc:source>
<dc:title>Determinants and Prognostic Value of Early Gadolinium Enhancement-Derived Myocardial Salvage Index in STEMI</dc:title>
<dc:identifier>pmid:40123493</dc:identifier>
<dc:identifier>doi:10.1161/CIRCIMAGING.124.017830</dc:identifier>
</item>
<item>
<title>Effects of Nicorandil, Isosorbide Mononitrate, or Diltiazem on Radial Artery Grafts After CABG: The Randomized ASRAB-Pilot Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123490/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In this pilot trial, treatment with nicorandil or isosorbide mononitrate was associated with a lower RA graft failure rate compared with diltiazem. Larger hypothesis-testing trials are warranted.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 24:e014542. doi: 10.1161/CIRCINTERVENTIONS.124.014542. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The optimal antispastic treatment after coronary artery bypass grafting using radial artery (RA) grafts is controversial. This clinical trial aimed to generate pilot comparative data on the effects of nicorandil, isosorbide mononitrate, or diltiazem on RA grafts.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a single-center, randomized, open-label, parallel-group pilot trial. Eligible patients who underwent coronary artery bypass grafting using RA grafts were randomized in a 1:1:1 ratio to receive oral nicorandil (15 mg daily), isosorbide mononitrate (50 mg daily), or diltiazem (180 mg daily) for 24 weeks post-coronary artery bypass grafting. The primary outcome was RA graft failure (modified Fitzgibbon grade B, S, or O) at 1 and 24 weeks, assessed by coronary computed tomography angiography.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 150 randomized participants, 149 (mean age, 56.8 years; 13.4% women) with 177 RA grafts were assessed at least once by coronary computed tomography angiography, including 50 participants with 64 RA grafts in the nicorandil group, 50 participants with 57 RA grafts in the isosorbide mononitrate group, and 49 participants with 56 RA grafts in the diltiazem group, respectively. At 1 week post-coronary artery bypass grafting, the RA graft failure rates were lower with nicorandil versus diltiazem (19.4% versus 25.0%; difference, -5.6% [95% CI, -20.6% to 9.3%]) and isosorbide mononitrate versus diltiazem (18.2% versus 25.0%; difference, -6.8% [95% CI, -21.8% to 8.6%]). The RA graft failure rates were slightly higher with nicorandil versus isosorbide mononitrate (19.4% versus 18.2%; difference, 1.2% [95% CI, -13.3% to 15.2%]). At 24 weeks, RA graft failure rates were lower with nicorandil versus diltiazem (16.1% versus 27.8%; difference, -11.7% [95% CI, -26.6% to 3.4%]), and isosorbide mononitrate versus diltiazem (12.5% versus 27.8%; difference, -15.3% [95% CI, -29.8% to -0.2%]), and slightly higher with nicorandil versus isosorbide mononitrate (16.1% versus 12.5%; difference, 3.6% [95% CI, -9.6% to 16.4%]).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In this pilot trial, treatment with nicorandil or isosorbide mononitrate was associated with a lower RA graft failure rate compared with diltiazem. Larger hypothesis-testing trials are warranted.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04310995.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123490/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123490</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.124.014542>10.1161/CIRCINTERVENTIONS.124.014542</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123490</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Yunpeng Zhu</dc:creator>
<dc:creator>Wei Zhang</dc:creator>
<dc:creator>Kaijie Qin</dc:creator>
<dc:creator>Yun Liu</dc:creator>
<dc:creator>Haoyi Yao</dc:creator>
<dc:creator>Zhe Wang</dc:creator>
<dc:creator>Xiaofeng Ye</dc:creator>
<dc:creator>Mi Zhou</dc:creator>
<dc:creator>Haiqing Li</dc:creator>
<dc:creator>Jiapei Qiu</dc:creator>
<dc:creator>Hong Xu</dc:creator>
<dc:creator>Yanjun Sun</dc:creator>
<dc:creator>Mario Gaudino</dc:creator>
<dc:creator>Qiang Zhao</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>Effects of Nicorandil, Isosorbide Mononitrate, or Diltiazem on Radial Artery Grafts After CABG: The Randomized ASRAB-Pilot Trial</dc:title>
<dc:identifier>pmid:40123490</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.124.014542</dc:identifier>
</item>
<item>
<title>How to Improve Radiation Protection in Interventional Cardiology Procedures</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123489/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>The use of ionizing radiation during cardiac catheterization procedures poses risks to patients and medical staff, both directly and indirectly through orthopedic injuries caused by lead aprons. In this review, we summarize recent advances in radiation protection in the cardiac catheterization laboratory and discuss the effectiveness of traditional and novel radiation protection strategies and equipment.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 24:e014808. doi: 10.1161/CIRCINTERVENTIONS.124.014808. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The use of ionizing radiation during cardiac catheterization procedures poses risks to patients and medical staff, both directly and indirectly through orthopedic injuries caused by lead aprons. In this review, we summarize recent advances in radiation protection in the cardiac catheterization laboratory and discuss the effectiveness of traditional and novel radiation protection strategies and equipment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123489/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123489</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.124.014808>10.1161/CIRCINTERVENTIONS.124.014808</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123489</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Dimitrios Strepkos</dc:creator>
<dc:creator>Athanasios Rempakos</dc:creator>
<dc:creator>Michaella Alexandrou</dc:creator>
<dc:creator>Deniz Mutlu</dc:creator>
<dc:creator>Pedro E P Carvalho</dc:creator>
<dc:creator>Ali Bahbah</dc:creator>
<dc:creator>Ryan D Madder</dc:creator>
<dc:creator>Simon R Dixon</dc:creator>
<dc:creator>Anastasios Milkas</dc:creator>
<dc:creator>Kevin J Croce</dc:creator>
<dc:creator>William J Nicholson</dc:creator>
<dc:creator>Lorenzo Azzalini</dc:creator>
<dc:creator>Bavana V Rangan</dc:creator>
<dc:creator>Olga C Mastrodemos</dc:creator>
<dc:creator>Konstantinos Voudris</dc:creator>
<dc:creator>Ahmed Al-Ogaili</dc:creator>
<dc:creator>M Nicholas Burke</dc:creator>
<dc:creator>Yader Sandoval</dc:creator>
<dc:creator>Emmanouil S Brilakis</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>How to Improve Radiation Protection in Interventional Cardiology Procedures</dc:title>
<dc:identifier>pmid:40123489</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.124.014808</dc:identifier>
</item>
<item>
<title>Enhancing Stroke Awareness and Activation Among High-Risk Populations: A Randomized Direct Mail Intervention in Diverse Healthcare Settings</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123486/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: A mailed message including a $5 incentive was more effective than a standard message in engaging high-risk patients with their healthcare system, including a salience message may also be important in some patient populations. Many primary care patients are unaware of their stroke risk.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Qual Outcomes. 2025 Mar 24:e011425. doi: 10.1161/CIRCOUTCOMES.124.011425. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Many patients are unaware of their stroke risk. The purpose of this research was to compare the effect of behaviorally tailored mailed messages on patient activation to reduce stroke risk.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Randomized parallel group clinical trial. We used electronic health records to construct Framingham Stroke Risk Scores in primary care patients from 1 Veterans Health Administration (VA) and 1 non-VA healthcare system, Eskenazi Health System (EHS). Four stroke risk messages were developed through patient interviews: standard, incentive ($5 gift card), salience, and incentive plus salience. The standard message served as the comparison group. Patients in the highest Framingham Stroke Risk Score quintile were randomly assigned to receive one of the messages. All letters asked the patient to call a stroke prevention coordinator, the primary outcome. Response to the messages was modeled separately in the 2 cohorts using logistic regression.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In total, 2084 EHS patients (mean age, 65.6; 36% male; 68% Black; mean Framingham Stroke Risk Score, 13.1) and 1759 VA patients (mean age, 75.6; 99% male; 86% White; mean Framingham Stroke Risk Score, 18.6) received a letter. Rates of calls to the coordinator were 13% among the EHS and 23% among the VA cohort. The EHS cohort was significantly more likely to respond to the incentive message compared with the standard message (odds ratio, 1.97 [95% CI, 1.17-3.09]), and the VA cohort was more likely to respond to the incentive plus salience message (odds ratio, 1.50 [95% CI, 1.02-2.22]). Among individuals calling the coordinator, 31% of the EHS cohort and 27% of the VA cohort were unaware they had stroke risk factors.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: A mailed message including a $5 incentive was more effective than a standard message in engaging high-risk patients with their healthcare system, including a salience message may also be important in some patient populations. Many primary care patients are unaware of their stroke risk.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02721446.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123486/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123486</a> | DOI:<a href=https://doi.org/10.1161/CIRCOUTCOMES.124.011425>10.1161/CIRCOUTCOMES.124.011425</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123486</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Christine C Groves</dc:creator>
<dc:creator>Teresa M Damush</dc:creator>
<dc:creator>Laura J Myers</dc:creator>
<dc:creator>Fitsum Baye</dc:creator>
<dc:creator>Joanne K Daggy</dc:creator>
<dc:creator>Anthony J Perkins</dc:creator>
<dc:creator>Holly Martin</dc:creator>
<dc:creator>Layne Mounsey</dc:creator>
<dc:creator>Daniel O Clark</dc:creator>
<dc:creator>Linda S Williams</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation. Cardiovascular quality and outcomes</dc:source>
<dc:title>Enhancing Stroke Awareness and Activation Among High-Risk Populations: A Randomized Direct Mail Intervention in Diverse Healthcare Settings</dc:title>
<dc:identifier>pmid:40123486</dc:identifier>
<dc:identifier>doi:10.1161/CIRCOUTCOMES.124.011425</dc:identifier>
</item>
<item>
<title>Natural History and Clinical Outcomes of Patients With &lt;em>;DSG2/DSC2&lt;/em>; Variant-Related Arrhythmogenic Right Ventricular Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40123482/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: ARVC attributable to variants in desmosomal cadherins mostly present with right ventricular or biventricular disease. Multiple variants are common in these patients and are associated with more frequent clinical penetrance, earlier onset of disease, and adverse clinical outcomes.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 24. doi: 10.1161/CIRCULATIONAHA.124.072226. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Genetic variants in desmosomal cadherins, desmoglein 2 (<i>DSG2</i>) and desmocollin 2 (<i>DSC2</i>), cause a distinct form of arrhythmogenic right ventricular cardiomyopathy (ARVC), which remains poorly reported. In this study, we aimed to provide a comprehensive description of the phenotypic expression, natural history, and clinical outcomes of patients with this ARVC subset.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Genetic and clinical data of <i>DSG2</i> and <i>DSC2</i> variant carriers were collected from 5 countries in Europe and Asia. We assessed the phenotypic profile of these patients and their clinical outcomes, focusing on heart failure and ventricular arrhythmia events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Overall, 271 subjects, 254 with <i>DSG2</i> variants, were included in this study (median age, 38 years [interquartile range, 25-52]; 62.7% male). Of these, 165 were probands, and 200 were diagnosed with definite ARVC. A total of 181 (66.8%) individuals carried missense variants, mainly distributed in the extracellular domains. Notably, we included 78 (28.8%) individuals with multiple variants. Of the 200 cases with diagnosed ARVC, 41 (20.5%) experienced premature cardiac death before the age of 65. Among the 81 individuals for whom both left ventricular ejection fraction and right ventricular fractional area change data were available at presentation, 29 (35.8%) had isolated right ventricular dysfunction, and 16 (19.8%) had biventricular dysfunction. Single-variant carriers who engaged in intense physical exercise were younger at disease onset compared with those who did not (<i>P</i>=0.001). Compared with single-variant carriers, those with multiple variants were more likely to be diagnosed with ARVC (96.2% versus 64.8%; <i>P</i>&lt;0.001) and exhibited more severe left ventricular dysfunction (44.4% versus 22.1%; <i>P</i>=0.001) and right ventricular dilation (88.9% versus 55.8%, <i>P</i>&lt;0.001). Multiple-variant carriers were significantly younger at ARVC diagnosis compared with single-variant carriers (33 [18-49] years versus 42 [27-54] years; <i>P</i>&lt;0.001]. During follow-up, end-stage heart failure (<i>P</i>&lt;0.001) and malignant ventricular arrhythmias (<i>P</i>=0.004) were significantly more frequent in multiple-variant compared with single-variant carriers. Compared with <i>PKP2</i> patients, <i>DSG2/DSC2</i> patients exhibited a significantly higher risk of end-stage heart failure (<i>P</i>&lt;0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: ARVC attributable to variants in desmosomal cadherins mostly present with right ventricular or biventricular disease. Multiple variants are common in these patients and are associated with more frequent clinical penetrance, earlier onset of disease, and adverse clinical outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40123482/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40123482</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072226>10.1161/CIRCULATIONAHA.124.072226</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40123482</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Liang Chen</dc:creator>
<dc:creator>Yuxiao Hu</dc:creator>
<dc:creator>Ardan M Saguner</dc:creator>
<dc:creator>Barbara Bauce</dc:creator>
<dc:creator>Yaxin Liu</dc:creator>
<dc:creator>Anteng Shi</dc:creator>
<dc:creator>Fu Guan</dc:creator>
<dc:creator>Zhongli Chen</dc:creator>
<dc:creator>Maria Bueno Marinas</dc:creator>
<dc:creator>Lingmin Wu</dc:creator>
<dc:creator>Deborah Foltran</dc:creator>
<dc:creator>Alexis Hermida</dc:creator>
<dc:creator>Veronique Fressart</dc:creator>
<dc:creator>Serena Pinci</dc:creator>
<dc:creator>Rudy Celeghin</dc:creator>
<dc:creator>Zixian Chen</dc:creator>
<dc:creator>Baowei Zhang</dc:creator>
<dc:creator>Lin Yubi</dc:creator>
<dc:creator>Xiaorui Liu</dc:creator>
<dc:creator>Marco Cason</dc:creator>
<dc:creator>Marika Martini</dc:creator>
<dc:creator>Ilaria Rigato</dc:creator>
<dc:creator>Corinna Brunckhorst</dc:creator>
<dc:creator>Ruth Biller</dc:creator>
<dc:creator>Cristina Basso</dc:creator>
<dc:creator>Bing Yang</dc:creator>
<dc:creator>Xiaoyan Zhao</dc:creator>
<dc:creator>Julia Cadrin-Tourigny</dc:creator>
<dc:creator>Alessio Gasperetti</dc:creator>
<dc:creator>Cynthia A James</dc:creator>
<dc:creator>Xianliang Zhou</dc:creator>
<dc:creator>Estelle Gandjbakhch</dc:creator>
<dc:creator>Kalliopi Pilichou</dc:creator>
<dc:creator>Firat Duru</dc:creator>
<dc:creator>Shengshou Hu</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Natural History and Clinical Outcomes of Patients With &lt;em>;DSG2/DSC2&lt;/em>; Variant-Related Arrhythmogenic Right Ventricular Cardiomyopathy</dc:title>
<dc:identifier>pmid:40123482</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072226</dc:identifier>
</item>
<item>
<title>Meningeal lymphatics-microglia axis regulates synaptic physiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40120575/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>Meningeal lymphatics serve as an outlet for cerebrospinal fluid, and their dysfunction is associated with various neurodegenerative conditions. Previous studies have demonstrated that dysfunctional meningeal lymphatics evoke behavioral changes, but the neural mechanisms underlying these changes have remained elusive. Here, we show that prolonged impairment of meningeal lymphatics alters the balance of cortical excitatory and inhibitory synaptic inputs, accompanied by deficits in memory tasks....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 14:S0092-8674(25)00210-7. doi: 10.1016/j.cell.2025.02.022. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Meningeal lymphatics serve as an outlet for cerebrospinal fluid, and their dysfunction is associated with various neurodegenerative conditions. Previous studies have demonstrated that dysfunctional meningeal lymphatics evoke behavioral changes, but the neural mechanisms underlying these changes have remained elusive. Here, we show that prolonged impairment of meningeal lymphatics alters the balance of cortical excitatory and inhibitory synaptic inputs, accompanied by deficits in memory tasks. These synaptic and behavioral alterations induced by lymphatic dysfunction are mediated by microglia, leading to increased expression of the interleukin 6 gene (Il6). IL-6 drives inhibitory synapse phenotypes via a combination of trans- and classical IL-6 signaling. Restoring meningeal lymphatic function in aged mice reverses age-associated synaptic and behavioral alterations. Our findings suggest that dysfunctional meningeal lymphatics adversely impact cortical circuitry through an IL-6-dependent mechanism and identify a potential target for treating aging-associated cognitive decline.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40120575/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40120575</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.02.022>10.1016/j.cell.2025.02.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40120575</guid>
<pubDate>Sat, 22 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Kyungdeok Kim</dc:creator>
<dc:creator>Daviti Abramishvili</dc:creator>
<dc:creator>Siling Du</dc:creator>
<dc:creator>Zachary Papadopoulos</dc:creator>
<dc:creator>Jay Cao</dc:creator>
<dc:creator>Jasmin Herz</dc:creator>
<dc:creator>Igor Smirnov</dc:creator>
<dc:creator>Jean-Leon Thomas</dc:creator>
<dc:creator>Marco Colonna</dc:creator>
<dc:creator>Jonathan Kipnis</dc:creator>
<dc:date>2025-03-22</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Meningeal lymphatics-microglia axis regulates synaptic physiology</dc:title>
<dc:identifier>pmid:40120575</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.02.022</dc:identifier>
</item>
<item>
<title>Microtubules in Asgard archaea</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40120574/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>Microtubules are a hallmark of eukaryotes. Archaeal and bacterial homologs of tubulins typically form homopolymers and non-tubular superstructures. The origin of heterodimeric tubulins assembling into microtubules remains unclear. Here, we report the discovery of microtubule-forming tubulins in Asgard archaea, the closest known relatives of eukaryotes. These Asgard tubulins (AtubA/B) are closely related to eukaryotic α/β-tubulins and the enigmatic bacterial tubulins BtubA/B. Proteomics of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 19:S0092-8674(25)00254-5. doi: 10.1016/j.cell.2025.02.027. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Microtubules are a hallmark of eukaryotes. Archaeal and bacterial homologs of tubulins typically form homopolymers and non-tubular superstructures. The origin of heterodimeric tubulins assembling into microtubules remains unclear. Here, we report the discovery of microtubule-forming tubulins in Asgard archaea, the closest known relatives of eukaryotes. These Asgard tubulins (AtubA/B) are closely related to eukaryotic α/β-tubulins and the enigmatic bacterial tubulins BtubA/B. Proteomics of Candidatus Lokiarchaeum ossiferum showed that AtubA/B were highly expressed. Cryoelectron microscopy structures demonstrate that AtubA/B form eukaryote-like heterodimers, which assembled into 5-protofilament bona fide microtubules in vitro. The additional paralog AtubB2 lacks a nucleotide-binding site and competitively displaced AtubB. These AtubA/B2 heterodimers polymerized into 7-protofilament non-canonical microtubules. In a sub-population of Ca. Lokiarchaeum ossiferum cells, cryo-tomography revealed tubular structures, while expansion microscopy identified AtubA/B cytoskeletal assemblies. Our findings suggest a pre-eukaryotic origin of microtubules and provide a framework for understanding the fundamental principles of microtubule assembly.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40120574/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40120574</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.02.027>10.1016/j.cell.2025.02.027</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40120574</guid>
<pubDate>Sat, 22 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Florian Wollweber</dc:creator>
<dc:creator>Jingwei Xu</dc:creator>
<dc:creator>Rafael I Ponce-Toledo</dc:creator>
<dc:creator>Florina Marxer</dc:creator>
<dc:creator>Thiago Rodrigues-Oliveira</dc:creator>
<dc:creator>Anja Pössnecker</dc:creator>
<dc:creator>Zhen-Hao Luo</dc:creator>
<dc:creator>Jessie James Limlingan Malit</dc:creator>
<dc:creator>Anastasiia Kokhanovska</dc:creator>
<dc:creator>Michal Wieczorek</dc:creator>
<dc:creator>Christa Schleper</dc:creator>
<dc:creator>Martin Pilhofer</dc:creator>
<dc:date>2025-03-22</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Microtubules in Asgard archaea</dc:title>
<dc:identifier>pmid:40120574</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.02.027</dc:identifier>
</item>
<item>
<title>Unlocking Prognostic Insights in severe tricuspid regurgitation: Impact of RV volumes and function by CMR</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40120094/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Thresholds of RV volume and function by CMR stratifying low-intermediate and high-risk of cardiovascular events are defined in a multicentre cohort of patients. Compared to low-risk group, high- and, to a lower extent, intermediate-risk group are independently associated to HF and all-cause mortality.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Imaging. 2025 Mar 22:jeaf097. doi: 10.1093/ehjci/jeaf097. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: to describe prognostic cut-off values of RV size and function by cardiac magnetic resonance (CMR) in a multicentre cohort of patients with severe TR.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: The study-enrolled patients with at least severe TR (severe, massive and torrential) assessed by 2D echocardiography who underwent a contemporary CMR study. The primary endpoint was defined as combined endpoint of all-cause mortality or hospitalization for heart failure events and the secondary endpoint was defined as cardiovascular mortality. 314 patients with severe TR were included in this study (70 ± 11 years, 67% female, 79% NYHA I or II). During a median follow-up of 35 months (IQR: 12-60), 39% of the patients experienced the combined endpoint. After adjusting for clinical and imaging variables, RV end-diastolic volume (RV-EDV) and RV ejection fraction (RVEF) were independently associated with all-cause mortality and HF (adj HR for RV-EDV: 1.015 [1.012-1.019], p&lt;0.001; adj HR for RVEF: 0.957 [0.938-0.976], p&lt;0.001). Thresholds of highest risk were defined by RV-EDV >; 150 ml/m² and RVEF &lt; 50%, while intermediate risk was defined by RV-EDV between 100-150 ml/m² and RVEF between 50-60%. Compared to low-risk groups, adjusted threshold for high-risk (adj HR for RV-EDV>;150 ml/m2: 5.42 [3.20-9.16] and for RVEF&lt;50%: 2.12 [1.21-3.71]) and intermediate-risk (adj HR for RV-EDV 100-150 ml/m2: 1.72 [1.11-2.64] and for RVEF 50 -60%: 1.59 [1.04- 2.43]) were significantly associated with impaired outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Thresholds of RV volume and function by CMR stratifying low-intermediate and high-risk of cardiovascular events are defined in a multicentre cohort of patients. Compared to low-risk group, high- and, to a lower extent, intermediate-risk group are independently associated to HF and all-cause mortality.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40120094/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40120094</a> | DOI:<a href=https://doi.org/10.1093/ehjci/jeaf097>10.1093/ehjci/jeaf097</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40120094</guid>
<pubDate>Sat, 22 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Rocio Hinojar</dc:creator>
<dc:creator>Jose Rodriguez Palomares</dc:creator>
<dc:creator>Rocio Eiros</dc:creator>
<dc:creator>Manuel Barreiro</dc:creator>
<dc:creator>Noemi Ramos</dc:creator>
<dc:creator>Sara Rodriguez Diego</dc:creator>
<dc:creator>Laura Gutiérrez</dc:creator>
<dc:creator>Maria José Calero</dc:creator>
<dc:creator>Alfonso Muriel</dc:creator>
<dc:creator>Ariana González Gómez</dc:creator>
<dc:creator>Ana García Martin</dc:creator>
<dc:creator>Covadonga Fernández-Golfín</dc:creator>
<dc:creator>Jose Luis Zamorano</dc:creator>
<dc:date>2025-03-22</dc:date>
<dc:source>European heart journal. Cardiovascular Imaging</dc:source>
<dc:title>Unlocking Prognostic Insights in severe tricuspid regurgitation: Impact of RV volumes and function by CMR</dc:title>
<dc:identifier>pmid:40120094</dc:identifier>
<dc:identifier>doi:10.1093/ehjci/jeaf097</dc:identifier>
</item>
<item>
<title>Changes in Coronary Disease Management Decisions in Real World Practice between 2015 and 2023: Insights from the Evarest/BSE-NSTEP observational study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40119705/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Coronary disease management pathways have changed within the UK and fewer patients with moderate ischaemia are undergoing invasive coronary angiography. However, coronary intervention rates are unchanged, suggesting stress echocardiography is being used to improve patient selection for invasive procedures, while minimising unnecessary referrals. Future work will assess if this reduction in angiography referrals is maintained long term, and if there are any effects on patient...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Imaging. 2025 Mar 22:jeaf099. doi: 10.1093/ehjci/jeaf099. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: To assess the real world impact of updated clinical guidelines and literature on the management of patients undergoing stress echocardiography for the assessment of inducible ischaemia across a national health service.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: A total of 13,819 patients from 32 UK hospitals, referred for stress echocardiography between 2015-2023, were analysed across two phases: phase 1 (2015-2020) and phase 2 (2020-2023). Follow-up data for one year was available for 4,920 participants through NHS Digital. Patients in phase 2 were younger, and presented with a higher cardiovascular risk profile, although sex distribution remained similar across phases. There was an observed reduction in invasive angiography referrals within one year following a positive stress echocardiogram (p&lt;0.01), which appeared to be attributed to changes in management of patients with moderate ischaemia (3-4 segments; p&lt;0.01). For those who did receive invasive assessment, there were no changes in intervention rate (p=0.27), regardless of ischaemic burden. This trend was most evident in centres performing a higher volume of stress echocardiograms.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Coronary disease management pathways have changed within the UK and fewer patients with moderate ischaemia are undergoing invasive coronary angiography. However, coronary intervention rates are unchanged, suggesting stress echocardiography is being used to improve patient selection for invasive procedures, while minimising unnecessary referrals. Future work will assess if this reduction in angiography referrals is maintained long term, and if there are any effects on patient outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40119705/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40119705</a> | DOI:<a href=https://doi.org/10.1093/ehjci/jeaf099>10.1093/ehjci/jeaf099</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40119705</guid>
<pubDate>Sat, 22 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Casey L Johnson</dc:creator>
<dc:creator>Samuel Krasner</dc:creator>
<dc:creator>William Woodward</dc:creator>
<dc:creator>Emma Mao</dc:creator>
<dc:creator>Annabelle McCourt</dc:creator>
<dc:creator>Cameron Dockerill</dc:creator>
<dc:creator>Katrin Balkhausen</dc:creator>
<dc:creator>Badrinathan Chandrasekaran</dc:creator>
<dc:creator>Attila Kardos</dc:creator>
<dc:creator>Nikant Sabharwal</dc:creator>
<dc:creator>Soroosh Firoozan</dc:creator>
<dc:creator>Rizwan Sarwar</dc:creator>
<dc:creator>Roxy Senior</dc:creator>
<dc:creator>Rajan Sharma</dc:creator>
<dc:creator>Kenneth Wong</dc:creator>
<dc:creator>Daniel X Augustine</dc:creator>
<dc:creator>Maria Paton</dc:creator>
<dc:creator>Jamie O'Driscoll</dc:creator>
<dc:creator>David Oxborough</dc:creator>
<dc:creator>Keith Pearce</dc:creator>
<dc:creator>Shaun Robinson</dc:creator>
<dc:creator>James Willis</dc:creator>
<dc:creator>Paul Leeson</dc:creator>
<dc:creator>EVAREST/BSE-NSTEP Investigators</dc:creator>
<dc:date>2025-03-22</dc:date>
<dc:source>European heart journal. Cardiovascular Imaging</dc:source>
<dc:title>Changes in Coronary Disease Management Decisions in Real World Practice between 2015 and 2023: Insights from the Evarest/BSE-NSTEP observational study</dc:title>
<dc:identifier>pmid:40119705</dc:identifier>
<dc:identifier>doi:10.1093/ehjci/jeaf099</dc:identifier>
</item>
<item>
<title>Answer: an uncommon electrocardiogram pattern in a case of acute chest pain</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40118096/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Acute Cardiovasc Care. 2025 Mar 22:zuaf020. doi: 10.1093/ehjacc/zuaf020. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40118096/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40118096</a> | DOI:<a href=https://doi.org/10.1093/ehjacc/zuaf020>10.1093/ehjacc/zuaf020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40118096</guid>
<pubDate>Fri, 21 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Gulbadin Mufti</dc:creator>
<dc:creator>Shahid H Shali</dc:creator>
<dc:creator>A Shaheer Ahmed</dc:creator>
<dc:date>2025-03-21</dc:date>
<dc:source>European heart journal. Acute cardiovascular care</dc:source>
<dc:title>Answer: an uncommon electrocardiogram pattern in a case of acute chest pain</dc:title>
<dc:identifier>pmid:40118096</dc:identifier>
<dc:identifier>doi:10.1093/ehjacc/zuaf020</dc:identifier>
</item>
<item>
<title>Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40118046/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>Understanding how proteins in different mammalian tissues are regulated is central to biology. Protein abundance, turnover, and post-translational modifications such as phosphorylation are key factors that determine tissue-specific proteome properties. However, these properties are challenging to study across tissues and remain poorly understood. Here, we present Turnover-PPT, a comprehensive resource mapping the abundance and lifetime of 11,000 proteins and 40,000 phosphosites in eight mouse...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 14:S0092-8674(25)00209-0. doi: 10.1016/j.cell.2025.02.021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Understanding how proteins in different mammalian tissues are regulated is central to biology. Protein abundance, turnover, and post-translational modifications such as phosphorylation are key factors that determine tissue-specific proteome properties. However, these properties are challenging to study across tissues and remain poorly understood. Here, we present Turnover-PPT, a comprehensive resource mapping the abundance and lifetime of 11,000 proteins and 40,000 phosphosites in eight mouse tissues and various brain regions using advanced proteomics and stable isotope labeling. We reveal tissue-specific short- and long-lived proteins, strong correlations between interacting protein lifetimes, and distinct impacts of phosphorylation on protein turnover. Notably, we discover a remarkable pattern of turnover changes for peroxisome proteins in specific tissues and that phosphorylation regulates the stability of neurodegeneration-related proteins, such as Tau and α-synuclein. Thus, Turnover-PPT provides fundamental insights into protein stability, tissue dynamic proteotypes, and functional protein phosphorylation and is accessible via an interactive web-based portal at https://yslproteomics.shinyapps.io/tissuePPT.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40118046/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40118046</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.02.021>10.1016/j.cell.2025.02.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40118046</guid>
<pubDate>Fri, 21 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Wenxue Li</dc:creator>
<dc:creator>Abhijit Dasgupta</dc:creator>
<dc:creator>Ka Yang</dc:creator>
<dc:creator>Shisheng Wang</dc:creator>
<dc:creator>Nisha Hemandhar-Kumar</dc:creator>
<dc:creator>Surendhar R Chepyala</dc:creator>
<dc:creator>Jay M Yarbro</dc:creator>
<dc:creator>Zhenyi Hu</dc:creator>
<dc:creator>Barbora Salovska</dc:creator>
<dc:creator>Eugenio F Fornasiero</dc:creator>
<dc:creator>Junmin Peng</dc:creator>
<dc:creator>Yansheng Liu</dc:creator>
<dc:date>2025-03-21</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regions</dc:title>
<dc:identifier>pmid:40118046</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.02.021</dc:identifier>
</item>
<item>
<title>SnapShot: Human sperm-egg interface proteins</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40118033/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>Human fertilization is a complex, highly regulated process that involves intricate molecular interactions between sperm and egg. Ultimately, this process culminates in the fusion of the gamete membranes to form a zygote. Gene disruption studies in mice have identified several critical fertilization factors. This SnapShot highlights the structure function of key proteins at the sperm-egg interface, providing insights into the mechanism of fertilization. To view this SnapShot, open or download the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 20;188(6):1746-1746.e1. doi: 10.1016/j.cell.2025.01.001.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Human fertilization is a complex, highly regulated process that involves intricate molecular interactions between sperm and egg. Ultimately, this process culminates in the fusion of the gamete membranes to form a zygote. Gene disruption studies in mice have identified several critical fertilization factors. This SnapShot highlights the structure function of key proteins at the sperm-egg interface, providing insights into the mechanism of fertilization. To view this SnapShot, open or download the PDF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40118033/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40118033</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.001>10.1016/j.cell.2025.01.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40118033</guid>
<pubDate>Fri, 21 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Emily Forster</dc:creator>
<dc:creator>Xinyin Wang</dc:creator>
<dc:creator>Abenan Thayaparan</dc:creator>
<dc:creator>Jeffrey E Lee</dc:creator>
<dc:date>2025-03-21</dc:date>
<dc:source>Cell</dc:source>
<dc:title>SnapShot: Human sperm-egg interface proteins</dc:title>
<dc:identifier>pmid:40118033</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.001</dc:identifier>
</item>
<item>
<title>Exploring the plant microbiome: A pathway to climate-smart crops</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40118032/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250324181112&amp;v=2.18.0.post9+e462414
      <description>The advent of semi-dwarf crop varieties and fertilizers during the Green Revolution boosted yields and food security. However, unintended consequences such as environmental pollution and greenhouse gas emissions underscore the need for strategies to mitigate these impacts. Manipulating rhizosphere microbiomes, an aspect overlooked during crop domestication, offers a pathway for sustainable agriculture. We propose that modulating plant microbiomes can help establish "climate-smart crops" that...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 20;188(6):1469-1485. doi: 10.1016/j.cell.2025.01.035.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The advent of semi-dwarf crop varieties and fertilizers during the Green Revolution boosted yields and food security. However, unintended consequences such as environmental pollution and greenhouse gas emissions underscore the need for strategies to mitigate these impacts. Manipulating rhizosphere microbiomes, an aspect overlooked during crop domestication, offers a pathway for sustainable agriculture. We propose that modulating plant microbiomes can help establish "climate-smart crops" that improve yield and reduce negative impacts on the environment. Our proposed framework integrates plant genotype, root exudates, and microbes to optimize nutrient cycling, improve stress resilience, and expedite carbon sequestration. Integrating unselected ecological traits into crop breeding can promote agricultural sustainability, illuminating the nexus between plant genetics and ecosystem functioning.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40118032/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250324181112&v=2.18.0.post9+e462414">40118032</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.035>10.1016/j.cell.2025.01.035</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40118032</guid>
<pubDate>Fri, 21 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>An-Hui Ge</dc:creator>
<dc:creator>Ertao Wang</dc:creator>
<dc:date>2025-03-21</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Exploring the plant microbiome: A pathway to climate-smart crops</dc:title>
<dc:identifier>pmid:40118032</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.035</dc:identifier>
</item>





























</channel>
</rss>